title: Management of patients with implantable cardioverter defibrillators at emergency departments.
abstract: BACKGROUND
  With rapid improvements in technology and accumulation of clinical evidence, the implantable cardioverter defibrillator (ICD) has become a standard treatment for either primary or secondary prevention of sudden cardiac death. However, no analysis based on the perspective of emergency department has been reported, and managing patients with ICD remains a challenge to the emergency department doctors.
  
  
  METHODS
  This study reviewed the emergency department visits of patients who received ICD implantation in a single university hospital from 1995 to 2004. The baseline demographic and laboratory data were compared between groups with the non-parametric method of the Mann-Whitney U test for continuous data and the chi2 test for categorical data; p<0.05 was considered significant.
  
  
  RESULTS
  81 patients (56 men and 25 women) were included in this study. 43% of patients had at least one emergency department visit during the follow-up period, and a total of 86 emergency department visits were recorded. The most frequent aetiology of emergency department visits was ICD discharge (37 episodes; 43.1%) and the most frequent presenting symptom was electric shock sensation (25 episodes; 29.1%). Only 11 (12.8%) emergency department visits were because of non-cardiac aetiologies. Patients with emergency department visits had significant lower left ventricular ejection fraction (mean (SD) 41.5 (19.8) v 55.2 (18.4) ejection fraction units; p = 0.005) and more use of warfarin (8.6% v 0%; p<0.05). Although most emergency department visits were device or arrhythmia related, the acute coronary syndrome and congestive heart failure still accounted for 27.9% of hospital returns in combination.
  
  
  CONCLUSIONS
  Defibrillator discharge, acute coronary syndrome and heart failure constitute most aetiologies of emergency department visits of patients with ICD. The risk factors include lower left ventricular ejection fraction and use of warfarin.
authors.affiliation: Department of Internal Medicine (Division of Cardiology), Yuan's General Hospital, Kaohsiung, Taiwan.
authors.forename: Chung-Pin
authors.initials: CP
authors.lastname: Liu
authors.forename: Yi-Lwun
authors.initials: YL
authors.lastname: Ho
authors.forename: Yen-Hung
authors.initials: YH
authors.lastname: Lin
authors.forename: Yen-Bin
authors.initials: YB
authors.lastname: Liu
authors.forename: Wei-Tien
authors.initials: WT
authors.lastname: Chang
authors.forename: Chien-Hua
authors.initials: CH
authors.lastname: Huang
authors.forename: Wen-Jone
authors.initials: WJ
authors.lastname: Chen
mesh_terms: D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable / Q000009:adverse effects; D004556:Electric Injuries / Q000209:etiology / Q000628:therapy*; D004636:Emergency Service, Hospital; D005260:Female; D006331:Heart Diseases / Q000628:therapy*; D006801:Humans; D008297:Male